Clearmind Medicine Acquires Global Rights for PTSD Treatment Compounds

May 7, 2024

DENVER, Colo., May 07, 2024 (247marketnews.com)- Clearmind Medicine Inc. (Nasdaq:CMND) stated that it secured the exclusive patent licensing rights from Yissum Research Development Company of the Hebrew University of Jerusalem, which provides Clearmind with global rights to further develop, manufacture, and commercialize compounds that are targeted at treating post-traumatic stress disorder (PTSD) and other mental health conditions.

Dr. Adi Zullof-Shani, CEO of Clearmind, commented, “We are excited to announce this groundbreaking patent license agreement, which reflects our strong collaboration with Yissum and the Hebrew University, a world-leading institution. This agreement marks a significant stride in our mission to meet urgent mental health care needs. We believe that the psychedelic compounds covered by this agreement hold immense promise in treating complex conditions like PTSD, offering a new ray of hope to millions of people worldwide.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (CMND)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.